Conditions: Acromegaly
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 124
Healthy volunteers: no

Brief summary:
The purpose of the study is to assess the efficacy of an extended injection interval schedule of lanreotide Autogel 120 mg in acromegalic subjects who are biochemically controlled on long term treatment with octreotide LAR 10 or 20 mg

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Lanreotide Autogel 120 mg
Intervention descriptions: intervention 1: 120mg, injections every 6 weeks, then depending on IGF-1 results at Week 24

Protocol document: